Objectives - Not only every patient is different, but also every drug. Drug dosage must be individualised and adjusted to the patient' s organ function (e.g, age, kidney) and severity of disease (e.g. outpatient, or intensive care).
DESCRIPTION OF WORK
Consortium - The original consortium has 4 small and medium sized enterprises (DatMO, IGESber, MediHeer, ZuPvien) and 4 research and technology developers (NEPharm, MWPharm, GPNott, HospOer). The basic components are available, namely the pharmacokinet.
Funding SchemeTHN - Thematic network contracts
2640 Raach Am Hochgebirge
9801 MJ Zuidhorn
701 85 Oerebro
9712 CP Groningen
NG7 2RD Nottingham